Agreement builds on the companies’ ongoing partnership to expand choice and simplify diabetes management NORTHRIDGE, Calif., June 3, 2026 /PRNewswire/ — MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
